小分子在丙肝中的治疗——机会与挑战
—— 作者: 时间:2008-08-05
阅读数:
1325
简介:Debio 025 at daily doses of 1000 or 600 mg demonstrates an additive anti-HCV effect in combination with PegIFNa-2a. This effect was more evident in patients with genotype 1 & 4.Debio 025 in daily doses of 200 or 600 mg in combination with PegIFNa-2a was well tolerated and the majority of reported adverse events were known side effects of alpha interferons.
请登录后查看详细内容
标签:
中文幻灯
精彩幻灯
病毒性肝炎
发表评论
全部评论